Prognosis of patients with intermediate risk IPSS‐R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS‐R
暂无分享,去创建一个
M. Andreeff | H. Kantarjian | G. Garcia-Manero | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | D. Steensma | J. Ning | M. Sekeres | A. Nazha | G. Roboz | G. N. Nogueras Gonzalez | D. Sallman | R. Komrokji | Maliha Khan | A. DeZern | S. Pierce | C. Benton | Jin Piao | N. A. Al Ali | F. Aung | Najla H. Al Ali